Ottobock stock slips 1.28% ahead of Thursday's Q3 update
Published on 11/10/2026 at 17:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Watch Next
- Ottobock will publish its third-quarter 2026 quarterly communication on Thursday, November 12.
- The update will provide fresh information on revenue momentum, regional performance and the full-year outlook.
- The company operates in prosthetics, neuro-orthotics and exoskeletons.
Ottobock stock slipped from 47.05 euros at 12:02 p.m. CET to 46.45 euros at 5:10 p.m. CET on Tuesday, November 10, on Lang & Schwarz. That 1.28 percent decline since the latest report's midday quote leaves the medical technology group heading into its scheduled third-quarter update.
Thursday Update Sets Next Test
Ottobock will publish its third-quarter 2026 quarterly communication on Thursday, November 12, in Duderstadt, according to Ottobock investor relations. The release is the next clear reference point for revenue momentum, regional performance and the company's full-year outlook.
The company operates in prosthetics, neuro-orthotics and exoskeletons. Its investor-relations site reports fiscal 2025 core revenue of 0.21 billion euros, up 11.7 percent, alongside adjusted core EBITDA of 54.77 million euros, up 29.5 percent.
Focus On Regional Performance
For investors, the quarterly communication should show whether the recent operating momentum continued into the third quarter and how regional trends shaped profitability. North American performance will be an important part of that assessment because it can affect both growth quality and the durability of the company's outlook.
Ottobock at a Glance
- Company: Ottobock SE & Co. KGaA
- ISIN: DE000BCK2223
- Lang & Schwarz quote: 46.45 euros at 5:10 p.m. CET on Tuesday, November 10, 2026
- Next scheduled event: Third-quarter 2026 quarterly communication on Thursday, November 12, 2026
European equities remain the broader backdrop for the upcoming company update; see the latest DAX market coverage.
More news and analyses are available on Ottobock stock.
